Skip to main content
Caplight Logo









Access Vascular, Inc.

Access Vascular, Inc.

Private
Billerica, MassachusettsHealthcare & Life Scienceshttps://www.accessvascularinc.com/

Last Round

Series C

Oct 31, 2023

Total Funding Raised

$45.7M

Momentum

Top 25%

of companies Caplight tracks

Company Overview

Access Vascular, Inc. is a medical device company that develops and manufactures a suite of venous access devices, including PICCs and midlines, using proprietary hydrophilic biomaterial technology to reduce vascular access complications.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Advanced Materials

Business Model

B2B

Customer Profile

Hardware Sales

AI Layer

Non-AI

Keywords

venous access cathetersPICCperipherally inserted central cathetermidline cathetershydrophilic biomaterialvascular accessmedical devicescatheter complicationsthrombosis preventionphlebitis reductionbiomaterialsvascular access teaminfusion therapyhospital suppliesmedtech

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Access Vascular, Inc. Comparables

Compare Access Vascular, Inc. with similar companies based on industry and business-model similarity.

Access Vascular, Inc. comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Neomend
82%
Medical Components, Inc.
79%
Shandong Weigao Group Medical Polymer Co Ltd
76%

Access Vascular, Inc. Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series COct 31, 2023
Series BMar 3, 2021
VC RoundSep 26, 2019
VC RoundOct 2, 2018
AngelAug 29, 2017

Key People

Founding team and executive leadership

James Biggins

President and CEO

Executive Team

Access Vascular, Inc. Investors

Notable investors and investment history

Access Vascular, Inc. investors
InvestorRounds
TVM CapitalSeries C, Series B
Green Park & Golf VenturesSeries C
AngelMDAngel

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jul 25, 2026

    Monthly visitors increased 39% MoM, from 3.6K to 5K.

  • Oct 31, 2023

    $22M round with Green Park & Golf Ventures and TVM Capital.

Access Vascular, Inc. Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Access Vascular, Inc. Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Access Vascular, Inc.'s valuation, stock price, and market status.

Firmographic Details

HeadquartersBillerica, Massachusetts
Employee Range34
Year Founded2015
Last FundingOct 31, 2023

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?